72 Results

People

  1. Wolden
    Wolden
  2. Zelefsky
    Zelefsky
  3. Motzer
    Motzer
  4. Ganly
    Ganly
  5. Kollmeier
    Kollmeier
  6. Patel
    Patel
  7. Tuttle
    Tuttle
  8. Vickers
    Vickers
  9. Cohen
    Cohen
  10. Ehdaie
    Ehdaie

Groups

  1. Survivorship Research (25)
  2. Department of Medicine (24)
  3. Surgery (22)
  4. Center for Hematologic Malignancies (17)
  5. Radiation Oncology, Department of (14)
  6. Epidemiology and Biostatistics (13)
  7. Solid Tumor Oncology Division (13)
  8. Pediatric Leukemia (11)
  9. Population Sciences Research Program (11)
  10. Genitourinary Oncology Service (10)
  1. "intermediate risk patient"
Formats
  1. Journal Article (62)
  2. Editorial (4)
  3. Guidelines (3)
  4. Review (2)
  5. Research Letter (1)
Groups
  1. Survivorship Research (25)
  2. Department of Medicine (24)
  3. Surgery (22)
  4. Center for Hematologic Malignancies (17)
  5. Radiation Oncology, Department of (14)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Suzanne Wolden (8)
  2. Michael Zelefsky (7)
  3. Robert Motzer (6)
  4. Ian Ganly (5)
  5. Andrew Vickers (4)
  6. Marisa Kollmeier (4)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (6)

More Years

Publications
  1. Lancet Oncology (5)
  2. European Urology (4)
  3. Gynecologic Oncology (4)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. Journal of Clinical Oncology (4)
  6. Journal of Urology (4)

More Publications

Publishers
  1. Elsevier Science, Inc. (16)
  2. Elsevier Inc. (14)
  3. Wiley Blackwell (8)
  4. American Society of Clinical Oncology (4)
  5. Lippincott Williams & Wilkins (4)
  6. American Society of Hematology (3)

More Publishers

Results (72)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): A 120 case single institution series
    Journal Article

    Montanari, F.; Radeski, D.; Seshan, V.; Alobeid, B.; Bhagat, G.; O'Connor, O. A.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer
    Journal Article

    Iyer, N. G.; Dogan, S.; Palmer, F.; Rahmati, R.; Nixon, I. J.; Lee, N.; Patel, S. G.; Shah, J. P.; Ganly, I.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Testicular cancer, version 2.2015
    Journal Article

    Motzer, R. J.; Jonasch, E.; Agarwal, N.; Beard, C.; Bhayani, S.; Bolger, G. B.; Chang, S. S.; Choueiri, T. K.; Costello, B. A.; Derweesh, I. H.; more...
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
    Journal Article

    Rodeberg, D. A.; Wharam, M. D.; Lyden, E. R.; Stoner, J. A.; Brown, K.; Wolden, S. L.; Paidas, C. N.; Donaldson, S. S.; Hawkins, D. S.; Spunt, S. L.; more...
    International Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma
    Journal Article

    Wang, L. Y.; Smith, A. W.; Palmer, F. L.; Tuttle, R. M.; Mahrous, A.; Nixon, I. J.; Patel, S. G.; Ganly, I.; Fagin, J. A.; Boucai, L.
    Thyroid (2015)

    Fulltext@MSK | Save
  • Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer
    Journal Article

    Cuaron, J.; Pei, X.; Cohen, G. N.; Cox, B. W.; Yamada, Y.; Zelefsky, M. J.; Kollmeier, M. A.
    Brachytherapy (2015)

    Fulltext@MSK | Save
  • Significance of lymphovascular space invasion in uterine serous carcinoma: What matters more; extent or presence?
    Journal Article

    Winer, I.; Ahmed, Q. F.; Mert, I.; Bandyopadhyay, S.; Cote, M.; Munkarah, A. R.; Hussein, Y.; Al-Wahab, Z.; Elshaikh, M. A.; Alosh, B.; more...
    International Journal of Gynecological Pathology (2014)

    Fulltext@MSK | Save
  • Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0031
    Journal Article

    Friedman, D. L.; Chen, L.; Wolden, S.; Buxton, A.; McCarten, K.; FitzGerald, T. J.; Kessel, S.; De Alarcon, P. A.; Chen, A. R.; Kobrinsky, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer
    Journal Article

    Spratt, D. E.; Zumsteg, Z. S.; Ghadjar, P.; Kollmeier, M. A.; Pei, X.; Cohen, G.; Polkinghorn, W.; Yamada, Y.; Zelefsky, M. J.
    BJU International (2014)

    Fulltext@MSK | Save
  • High-risk prostate cancer: From definition to contemporary management
    Journal Article

    Bastian, P. J.; Boorjian, S. A.; Bossi, A.; Briganti, A.; Heidenreich, A.; Freedland, S. J.; Montorsi, F.; Roach, M. 3rd; Schroder, F.; Van Poppel, H.; more...
    European Urology (2012)

    Fulltext@MSK | Save